Abstract:Bacterial communities exhibit significant heterogeneity, resulting in the emergence of specialized phenotypes that can withstand antibiotic exposure. Unfortunately, the existence of subpopulations resistant to antibiotics often goes unnoticed during treatment initiation. Thus, it is crucial to consider the concept of single-cell antibiotic susceptibility testing (AST) to tackle bacterial infections. Nevertheless, its practical application in clinical settings is hindered by its inability to conduct AST efficiently across a wide range of antibiotics and concentrations. This study introduces a droplet-based microfluidic platform designed for rapid single-cell AST by creating an antibiotic concentration gradient. The advantage of a microfluidic platform is achieved by executing bacteria and antibiotic mixing, cell encapsulation, incubation, and enumeration of bacteria in a seamless workflow, facilitating susceptibility testing of each antibiotic. Firstly, we demonstrate the rapid determination of minimum inhibitory concentration (MIC) of several antibiotics with Gram-negative E. coli and Gram-positive S. aureus, which enables us to bypass the time-consuming bacteria cultivation, speeding up the AST in 3 h from 1 to 2 days of conventional methods. Additionally, we assess 10 clinical isolates including methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Staphylococcus aureus (MDRSA) against clinically important antibiotics for analyzing the MIC, compared to the gold standard AST method from the United States Clinical and Laboratory Standards Institute (CLSI), which becomes available only after 48 h. Furthermore, by monitoring single cells within individual droplets, we have found a spectrum of resistance levels among genetically identical cells, revealing phenotypic heterogeneity within isogenic populations. This discovery not only advances clinical diagnostics and treatment strategies but also significantly contributes to the field of antibiotic stewardship, underlining the importance of our approach in addressing bacterial resistance.

Rapid and Accurate Antimicrobial Susceptibility Testing Using Label-Free Electrical Impedance-Based Microfluidic Platform

Rapid and Accurate Antimicrobial Susceptibility Testing Using Label‐Free Electrical Impedance‐Based Microfluidic Platform (Small 6/2024)

Rapid Antibiotic Susceptibility Testing in A Microfluidic Ph Sensor

Phase Contrast Image-Based Rapid Antimicrobial Susceptibility Testing of Bacteria in Liquid Culture Media

All-electrical antibiotic susceptibility testing within 30 min using silicon nano transistors

Precise Digital Bacteria Enumeration and Antibiotic Susceptibility Testing Via a Portable Vibrating Capillary-Based Droplet Platform

Microfluidic Systems for Rapid Antibiotic Susceptibility Tests (asts) at the Single-Cell Level

Dual-modal Detection of Antimicrobial Susceptibility in Pathogenic Bacteria Based on the High-Throughput Microfluidic Platform

Controlled-diffusion centrifugal microfluidic for rapid antibiotic susceptibility testing

Combinatorial Screening SlipChip for Rapid Phenotypic Antimicrobial Susceptibility Testing

Integrated Microfluidic Chip for Rapid Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures

A capillary-based centrifugal indicator equipped with in-situ pathogenic bacteria culture for fast antimicrobial susceptibility testing

A Multiplex Fluidic Chip for Rapid Phenotypic Antibiotic Susceptibility Testing

A Cascaded Droplet Microfluidic Platform Enables High-throughput Single Cell Antibiotic Susceptibility Testing at Scale

Rapid antibiotic susceptibility testing and species identification for mixed infections

Rapid Antibiotic Susceptibility Testing of Bacteria by Single-Field Tracking Centrifugation of Bacteria Solution

Microfluidic Technologies for Advanced Antimicrobial Susceptibility Testing

Label-free single-cell antimicrobial susceptibility testing in droplets with concentration gradient generation

Handyfuge Microfluidic for On-Site Antibiotic Susceptibility Testing

Rapid antibiotic susceptibility testing and species identification for mixed samples

Fiber-integrated cantilever-based nanomechanical biosensors as a tool for rapid antibiotic susceptibility testing